Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. [electronic resource]
Producer: 20200504Description: G109-G119 p. digitalISSN:- 1522-1547
- Anaplastic Lymphoma Kinase -- antagonists & inhibitors
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Autophagy -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cell Size -- drug effects
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm
- Extracellular Signal-Regulated MAP Kinases -- metabolism
- Humans
- Male
- Mice, Inbred BALB C
- Mice, Nude
- Pancreatic Neoplasms -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyrimidines -- pharmacology
- STAT3 Transcription Factor -- metabolism
- Signal Transduction
- Sulfones -- pharmacology
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.